406
Views
59
CrossRef citations to date
0
Altmetric
Gastrointestinal Cancers

IL-17A in the tumor microenvironment of the human colorectal adenoma–carcinoma sequence

, , &
Pages 1304-1312 | Received 13 May 2012, Accepted 19 Aug 2012, Published online: 19 Sep 2012
 

Abstract

Objectives. Interleukin (IL)-17A is an important pro-inflammatory cytokine and involved in the colorectal carcinogenesis. In this study, the authors evaluated the dynamic change of IL-17A expression in the tumor microenvironment throughout the colorectal adenoma–carcinoma sequence. Materials & methods. Using quantitative real-time PCR (polymerase chain reaction) and semi-quantitative immunohistochemistry, the authors examined the expression level of IL-17A in 50 of human colorectal adenoma tissues, 50 of colorectal cancer (CRC) tissues and 15 controls. The relationship between IL-17A expression and clinicopathological parameters throughout the sequence was also evaluated. Results. The results revealed a step-up increased IL-17A mRNA level throughout the colorectal adenoma–carcinoma sequence, which began to increase in the adenomas and became even higher in the CRCs; notably, the increase of IL-17A mRNA level in the adenomatous tissues was associated with the severity of dysplasia. Immunohistochemical analysis confirmed the real-time PCR results and revealed gradually increasing IL-17A cells in both the stroma and adenomatous/cancerous epithelium. In addition, the quantitative real-time PCR result has also revealed an increased expression of TH17-stimulating factors throughout the sequence. Conclusions. IL-17A and TH17 are highly activated throughout the colorectal adenoma–carcinoma sequence.

Acknowledgments

This work was financially supported by grant from National Nature Science Foundation of China (81071969) and Medical Research Program, Northern Norway Regional Health Authority (SFP-44-04) to G Cui.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.